Abstract:Objective:To explore the of traditional Chinese medicine on liver lipid per-oxidation and pathology in nonalcoholic fatty liver disease(NAFLD)rats.Methods:Fetched 72 wistar rats' level of SPF,females and males were half and half,were divided into 9 groups at random:normal group,model group,comparison medicine treatment group,medicine A treatment group,medicine B treatment group,first Medicine A then medicine B treatment group,first medicine B then medicine A treatment group,first blank then medicine A treatment group,first blank then,medicine B treatment group.Except the normal group was fed ordinary diet,the other eight groups were fed by high fat and high cholesterol diet.After 4 weeks later,model group rats were given hpysiological saline by intragastric administration.Comparison medicine treatment group rats were given comparision medicine by intragastric administration.Medicine A treatment group rats were given medicine A by intragastric administration.Medicine B treatment group rats were given medicine B by intragastric administration.First medicine A then medicine B treatment group rats were given medicine A from 4 weeks to 8 weeks and medicine B from 8 weeks to 12 weeks by intragastric administration.First medicine B then medicine A treatment group rats were given medicine B from 4 weeks to 8 weeks and medicine A from 8 weeks to 12 weeks by intragastric administration.First blank then medicine A treatment group rats were given nothing from 4 weeks to 8 weeks and medicine A from 8 weeks to 12 weeks by intragastric administration.First blank then medicine B treatment group rats were given nothing from 4 weeks to 8 weeks and medicine B from 8 weeks to 12 weeks by intragastric administration.At the end of the 12 weeks,we determined the content of SOD,MDA and GSH-ST and evaluated the degree of fat denatured and the activity of pathology inflammation in rat liver organization.Results:At the end of the 12 weeks,first medicine A then medicine B treatment group had better curative effect than other treatment groups at raising the content of SOD and GSH-ST(P0.01),and reducing the peroxide content of MDA(P0.01 or P0.05)in rat liver organization;ln pathology influence aspect,first medicine A then medicine B treatment group had better curative effect than other treatment groups at relieving the degree of fat denatured and the activity of pathology inflammation in later stage of NAFLD rats(P0.01 or P0.05).Conclusion:In NAFLD entire course of disease,treatment plan of applying therapy of dispersing the depressed liver-energy to invigorate the spleen,activating blood circulation to dissipate blood stasis and dissipating phlegm to decrease wet in early stage,using therapy of dissipating phlegm to dissipate blood stasis,clearing away heat evil to decrease wet and benefiting hepatorenal function in later stage,which had better curative effect than other remedial measures at elevating fatty liver cell oxidation resistance ability,reducing the lipid peroxidation product,the degree of fat denatured and the activity of pathology inflammation in NAFLD rats.

Influence of Soothing Liver and Invigorating Spleen Recipes on LXR Alpha mRNA of Liver Tissue and Protein Expression of NAFLD Rats

[Effect of Soothing Liver and Invigorating Spleen Recipes on SREBP-1c Mrna and Protein Expression in Hepatic Tissues of Rats with Non-Alcoholic Fatty Liver Disease].

Expressions of Key Regulatory Genes of the Lipid Metabolism in Livers During the Development of Rat Non-alcoholic Fatty Liver Disease

[Effects of Soothing Liver and Invigorating Spleen Recipes on the Mrna and Protein Expression of TLR4 in Hepatic Tissues of Rats with NASH].

Effects of Soothing liver and invigorating spleen methods and recipes on expression of NF-κB mRNA and protein in hepatic tissue of rats with non-alcoholic steatohepatitis

[Effects of Soothing Liver and Invigorating Spleen Recipes on NF-kappaB Signal Pathway Related Genes and Proteins in Primary Hepatocytes of Rats with NASH].

Effects of Soothing Liver and Invigorating Spleen Recipes of TCM on Hepatic Inflammatory Cytokines of Rats with Nonalcoholic Steatosishepatitis

Influence of traditional Chinese medicine on liver lipid per-oxidation and pathology in NAFLD rats

Identification of gene expression patterns in rat model of nonalcoholic fatty liver disease

Functional Proteomic Analysis of Nonalcoholic Fatty Liver Disease in Rat Models: Enoyl-coenzyme a Hydratase Down-Regulation Exacerbates Hepatic Steatosis

Experimental Study on Effect of Traditional Chinese Medicine Dialectical Treating Blood-fat Index on NAFLD Rats

Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease

Effects of Shugan-Jianpi Recipe on the Expression of the p38 MAPK/NF-κB Signaling Pathway in the Hepatocytes of NAFLD Rats

Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats

Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease

Study on effect and mechanism of Shenshaoruangan Decoction on liver fibrosis in rats

Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats

Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice

Chinese Herbal Medicine Formula Shenling Baizhu San Ameliorates High-Fat Diet-Induced NAFLD in Rats by Modulating Hepatic MicroRNA Expression Profiles

Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c

Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice